Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Applovin
APP
|
+$810M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$748M |
| 3 |
Palantir
PLTR
|
+$504M |
| 4 |
Union Pacific
UNP
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$366M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.88B |
| 2 |
Meta Platforms (Facebook)
META
|
+$719M |
| 3 |
Broadcom
AVGO
|
+$683M |
| 4 |
Bank of America
BAC
|
+$675M |
| 5 |
Wells Fargo
WFC
|
+$631M |
Sector Composition
| 1 | Technology | 16.39% |
| 2 | Financials | 13.7% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGMS
3451
DELISTED
IGM Biosciences
IGMS
| $308K | ﹤0.01% |
+275,112
| New | +$308K |
|
|
VBNK
3452
VersaBank
VBNK
$391M
| $307K | ﹤0.01% |
26,932
-17,605
| -40% | -$201K |
|
3453
California Water Service
CWT
$2.72B
| $306K | ﹤0.01% |
+6,735
| New | +$306K |
|
3454
Chunghwa Telecom
CHT
$34.5B
| $306K | ﹤0.01% |
+6,570
| New | +$306K |
|
3455
Galectin Therapeutics
GALT
$320M
| $305K | ﹤0.01% |
+144,528
| New | +$305K |
|
|
TEAD
3456
Teads Holding Co. Common Stock
TEAD
$149M
| $304K | ﹤0.01% |
122,492
-157,914
| -56% | -$392K |
|
3457
Altimmune
ALT
$324M
| $303K | ﹤0.01% |
78,294
-1,033,005
| -93% | -$4M |
|
3458
LINKBANCORP
LNKB
$270M
| $300K | ﹤0.01% |
41,023
+21,032
| +105% | +$154K |
|
3459
Alight
ALIT
$1.89B
| $300K | ﹤0.01% |
52,956
-106,076
| -67% | -$600K |
|
|
AVR
3460
Anteris Technologies Global Corp. Common Stock
AVR
$174M
| $299K | ﹤0.01% |
78,996
-281,148
| -78% | -$1.07M |
|
3461
Perma-Pipe International
PPIH
$261M
| $299K | ﹤0.01% |
+13,085
| New | +$299K |
|
3462
Autohome
ATHM
$3.4B
| $299K | ﹤0.01% |
11,601
-12,173
| -51% | -$314K |
|
3463
FibroBiologics
FBLG
$22.8M
| $299K | ﹤0.01% |
+480,645
| New | +$299K |
|
3464
Entravision Communication
EVC
$215M
| $299K | ﹤0.01% |
128,676
+97,704
| +315% | +$227K |
|
3465
Liberty Latin America Class C
LILAK
$1.54B
| $298K | ﹤0.01% |
47,909
-349,536
| -88% | -$2.17M |
|
3466
Golden Entertainment
GDEN
$634M
| $296K | ﹤0.01% |
10,053
-125,210
| -93% | -$3.68M |
|
3467
Cato Corp
CATO
$89.6M
| $296K | ﹤0.01% |
105,186
-9,835
| -9% | -$27.6K |
|
3468
LENSAR
LNSR
$145M
| $295K | ﹤0.01% |
22,378
-74,899
| -77% | -$986K |
|
3469
Highwoods Properties
HIW
$3.44B
| $294K | ﹤0.01% |
+9,467
| New | +$294K |
|
3470
iShare MSCI Eurozone ETF
EZU
$7.89B
| $294K | ﹤0.01% |
4,937
-130,827
| -96% | -$7.78M |
|
3471
Monte Rosa Therapeutics
GLUE
$296M
| $291K | ﹤0.01% |
64,631
-265,836
| -80% | -$1.2M |
|
3472
DHI Group
DHX
$143M
| $291K | ﹤0.01% |
98,029
-38,994
| -28% | -$116K |
|
3473
Consensus Cloud Solutions
CCSI
$511M
| $291K | ﹤0.01% |
12,616
-8,761
| -41% | -$202K |
|
3474
Guess, Inc.
GES
$868M
| $291K | ﹤0.01% |
24,032
-581,649
| -96% | -$7.03M |
|
|
BRW
3475
Saba Capital Income & Opportunities Fund
BRW
$348M
| $290K | ﹤0.01% |
35,941
-31,094
| -46% | -$251K |
|